Epidermal keratinocytes mediate mechanical pain following neuropathic injury
表皮角质形成细胞介导神经性损伤后的机械性疼痛
基本信息
- 批准号:10576798
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:Afferent NeuronsAgonistAnimalsAntineoplastic AgentsBehavioralBehavioral AssayCellsCentral Nervous SystemChemicalsChemotherapy-induced peripheral neuropathyChronicDataDevelopmentElectrophysiology (science)EpidermisExhibitsFiberGoalsGrowthHumanHyperalgesiaHypersensitivityIncubatedInjuryIon ChannelIon Channel GatingKnockout MiceMass Spectrum AnalysisMechanical StimulationMechanicsMediatingMolecular BiologyMusNerveNeuronsNeuropathyPaclitaxelPainPatientsPeripheralPeripheral Nervous System DiseasesPiezo 1 ion channelPre-Clinical ModelPropertyRoleSignal TransductionSkinSkin TissueSmall Interfering RNASodium ChannelTactileTestingTherapeuticTissue DonorsTouch sensationTransgenic MiceWorkafferent nervebehavioral responsebiomedical scientistcareercell typechronic neuropathic painchronic painhuman modelinflammatory paininjuredkeratinocyteknock-downmechanical allodyniamechanical stimulusmechanotransductionmouse modelnerve injurypainful neuropathypatch clamprelease factorsensory neuropathyside effectskillstissue injuryvoltage
项目摘要
Project Summary
Keratinocytes, the most abundant cell type in the epidermis, mediate normal touch sensation by detecting and
encoding tactile information to sensory neurons. However, it is unknown if keratinocyte mechanotransduction
contributes to chronic mechanical pain following tissue injury. My preliminary data suggest that keratinocytes
isolated from nerve injured animals are sensitized to mechanical stimulation. Considering this finding, I propose
to investigate if injury induced sensitization of keratinocyte mechanotransduction contributes to the development
of touch evoked neuropathic pain. I will specifically examine if this sensitization is mediated by the mechanically
gated ion channel PIEZO1, which my preliminary data suggests is a major keratinocyte mechanotransducer.
Here in Aim 1, I hypothesize that sensitization of keratinocyte PIEZO1 contributes to the development of chronic
mechanical pain in a mouse model chemotherapy-induced peripheral neuropathy (CIPN). I will utilize epidermal
specific PIEZO1 knockout mice and mechanical behavioral assays to determine if loss of PIEZO1 protects
against CIPN mechanical pain (Aim 1A). Additionally, I will utilize ex vivo skin nerve (Aim 1B) and whole-cell
patch clamp (Aim 1C) recordings to determine if loss of keratinocyte PIEZO1 reduces CIPN sensory nerve and
keratinocyte mechanical hypersensitivity. In Aim 2, I hypothesize that PIEZO1 mediates human keratinocyte
mechanotransduction. I will utilize whole-cell patch electrophysiology and PIEZO1 targeted siRNA to determine
if knockdown of PIEZO1 reduces human keratinocyte mechanical sensitivity (Aim 2A). Next, I will determine if
incubation with the chemotherapeutic paclitaxel sensitizes human keratinocytes to mechanical stimulation and if
PIEZO1 knockdown reduces this hypersensitivity (Aim 2B). Finally, I will use mass spectrometry to investigate
signaling factors released from human keratinocytes by PIEZO1 activation under naïve conditions and following
paclitaxel treatment (Aim 2C). Together these aims will determine if keratinocytes enhance evoked mechanical
pain following neuropathic injury and if epidermal PIEZO1 may be potentially targeted to relieve neuropathic
pain.
项目摘要
角质形成细胞是表皮中最丰富的细胞类型,通过检测和调节正常的触觉,
将触觉信息编码到感觉神经元。然而,角质形成细胞的机械转导是否
导致组织损伤后的慢性机械性疼痛。我的初步数据显示角质细胞
从神经损伤的动物中分离的细胞对机械刺激敏感。考虑到这一发现,我建议
研究损伤诱导的角质形成细胞机械转导的致敏是否有助于发展
触摸引起的神经性疼痛。我将特别检查这种致敏是否是由机械介导的,
门控离子通道PIEZO 1,我的初步数据表明,这是一个主要的角质形成细胞mechanotransducer。
在目的1中,我假设角质形成细胞PIEZO 1的致敏有助于慢性炎症的发展。
化学疗法诱导的周围神经病变(CIPN)小鼠模型中的机械性疼痛。我会利用表皮细胞
特异性PIEZO 1敲除小鼠和机械行为测定,以确定PIEZO 1的缺失是否保护
对抗CIPN机械性疼痛(Aim 1A)。此外,我将利用离体皮肤神经(Aim 1B)和全细胞
膜片钳(Aim 1C)记录以确定角质形成细胞PIEZO 1的损失是否减少CIPN感觉神经,
角质形成细胞机械过敏。在目的2中,我假设PIEZO 1介导人角质形成细胞
机械传导我将利用全细胞贴片电生理学和PIEZO 1靶向siRNA来确定
如果PIEZO 1的敲低降低人角质形成细胞的机械敏感性(Aim 2A)。接下来,我将确定
与化疗紫杉醇一起孵育使人角质形成细胞对机械刺激敏感,
PIEZO 1敲低降低了这种超敏反应(目的2B)。最后,我会用质谱仪来研究
在初始条件下和之后通过PIEZO 1活化从人角质形成细胞释放的信号传导因子
紫杉醇治疗(Aim 2C)。这些目标将共同确定角质形成细胞是否增强诱发的机械
神经性损伤后的疼痛,以及如果表皮PIEZO 1可以潜在地靶向缓解神经性损伤,
痛苦
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Mikesell其他文献
Alexander Mikesell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Mikesell', 18)}}的其他基金
Epidermal keratinocytes mediate mechanical pain following neuropathic injury
表皮角质形成细胞介导神经性损伤后的机械性疼痛
- 批准号:
10387370 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




